Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.000
-0.090 (-2.91%)
May 30, 2025, 4:00 PM - Market closed

Eledon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-19.05-36.18-116.54-87.97-34.51-22.81
Upgrade
Depreciation & Amortization
0.360.360.370.370.20.18
Upgrade
Asset Writedown & Restructuring Costs
---48.65--
Upgrade
Loss (Gain) From Sale of Investments
-2.99-2.8-1.2---
Upgrade
Stock-Based Compensation
14.2913.126.558.157.93.17
Upgrade
Other Operating Activities
-53.89-30.4876.21--2.354.43
Upgrade
Change in Accounts Payable
4.97.75-2.62.082.14-0.04
Upgrade
Change in Other Net Operating Assets
1.80.96-2.320.29-2.3-0.14
Upgrade
Operating Cash Flow
-54.59-47.27-39.53-28.42-28.91-15.21
Upgrade
Cash Acquisitions
-----11.04
Upgrade
Investment in Securities
-76.21-70.31-45.29---
Upgrade
Investing Cash Flow
-76.21-70.31-45.29--11.04
Upgrade
Issuance of Common Stock
133.64133.5233.02-014.38
Upgrade
Repurchase of Common Stock
------0.03
Upgrade
Other Financing Activities
-----0.45-
Upgrade
Financing Cash Flow
133.64133.5233.02--0.45109.58
Upgrade
Net Cash Flow
2.8415.94-51.8-28.42-29.36105.4
Upgrade
Free Cash Flow
-54.59-47.27-39.53-28.42-28.91-15.21
Upgrade
Free Cash Flow Per Share
-0.91-0.97-1.61-1.99-1.95-10.48
Upgrade
Levered Free Cash Flow
-27.89-21.4-24.47-13.85-15.33-4.01
Upgrade
Unlevered Free Cash Flow
-27.89-21.4-24.47-13.85-15.33-4.01
Upgrade
Change in Net Working Capital
-7.18-9.234.52-2.480.39-0.94
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q